October 17, 2022
Takeda Releases Report on the Importance of Defining Rare Disease in Canada
Read More
July 27, 2022
Pfizer Loses Appeal on Copay for Rare Heart Disease Drug
Read More
July 13, 2022
CORD Calls for the Creation of Pan-Canadian Centers of Excellence for Rare Disease
Read More
June 15, 2022
Eurodis and EFPIA Issue Joint Statement on Access to Medicines for Rare Disease Patients
Read More
June 8, 2022
Innovative Medicines Fund Financed with $427 (£340) Million to Provide Earlier Access to Cutting-Edge Treatments on NHS
Read More
May 25, 2022
Connecticut Establishes a Rare Disease Advisory Council
Read More
April 19, 2022
ICER Seeks Policy Debate on Balancing Innovation and Affordability of Orphan Drugs
Read More
April 8, 2022
Rare Disease Organizations Sign Call for Strengthening the Accelerated Approval Pathway
Read More
March 3, 2022
Eurodis Calls for International Community to Assist Ukrainian Rare Disease Community
Read More
March 2, 2022
Calculating the Costs of Rare Diseases
Read More
February 22, 2022
NORD Issues Annual State Report Cards on Rare Policy Issues
Read More
November 2, 2021
Rare Disease Diversity Coalition Calls on Congress to Preserve Orphan Drug Tax Credit
Read More
Load More
X